Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals has reported Accumulated Expenses for 4 years, with the latest figure at $572865.0 in Q4 2025.

• Quarterly Accumulated Expenses rose 90.96% year-over-year to $572865.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $572865.0 (up 90.96% YoY) and the FY2025 annual result came in at $572865.0, up 90.96% from the prior year.
• Accumulated Expenses improved to $572865.0 in Q4 2025 per MIRA's latest filing, from $5500.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $572865.0 in Q4 2025 and troughed at $5500.0 in Q1 2025.
• A 4-year average of $111819.9 and a median of $14472.0 in 2023 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 1972.97% in 2024, then tumbled 62.0% in 2025.
• Over 4 years, Accumulated Expenses stood at $34987.0 in 2022, then sank by 58.64% to $14472.0 in 2023, then soared by 1972.97% to $300000.0 in 2024, then surged by 90.96% to $572865.0 in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $572865.0, $5500.0, and $300000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.